XML 47 R27.htm IDEA: XBRL DOCUMENT
v3.23.1

Share-Based Compensation (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract] |
Summary of Activity Under Share-Based Compensation Plans | The following table summarizes the activity for all SARs under the Company’s share-based compensation plans for the three months ended March 31, 2023:
|  | Number of Awards |  |  | Weighted-Average Exercise Price Per Award |  |  | Weighted-Average Remaining Contractual Term |  | Aggregate Intrinsic Value(1) |
|  | (in thousands) |  |  |  |  |  |  |  | (in millions) |
Outstanding as of December 31, 2022(2) |  |  | 3,074 |  |  | $ | 24.21 |  |  | 4.6 years |  | $ | 0.3 |
Granted |  |  | 217 |  |  | $ | 20.17 |  |  |  |  |  |
Exercised |  |  | (7 | ) |  | $ | 15.22 |  |  |  |  |  |
Forfeited(3) |  |  | (157 | ) |  | $ | 28.58 |  |  |  |  |  |
Outstanding as of March 31, 2023(2) |  |  | 3,127 |  |  | $ | 23.73 |  |  | 4.9 years |  | $ | 1.7 |
Exercisable as of March 31, 2023(4) |  |  | 2,126 |  |  | $ | 27.52 |  |  | 2.6 years |  | $ | 0.4 |
Vested and expected to vest as of March 31, 2023(4) |  |  | 3,093 |  |  | $ | 23.83 |  |  | 4.9 years |  | $ | 1.6 |
(1) The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards. (2) Includes 0.7 million and 0.8 million performance condition SARs as of March 31, 2023 and December 31, 2022, respectively. (3) Includes 0.1 million performance condition SARs (4) Includes 0.7 million performance condition SARs The following table summarizes the activities for all restricted stock units under the Company’s share-based compensation plans for the three months ended March 31, 2023:
|  | Number of Shares |  |  | Weighted-Average Grant Date Fair Value Per Share |
|  | (in thousands) |  |  |  |
Outstanding and nonvested as of December 31, 2022(1) |  |  | 4,538 |  |  | $ | 33.14 |
Granted |  |  | 111 |  |  | $ | 20.17 |
Vested |  |  | (994 | ) |  | $ | 39.32 |
Forfeited |  |  | (57 | ) |  | $ | 40.76 |
Outstanding and nonvested as of March 31, 2023(1) |  |  | 3,598 |  |  | $ | 30.91 |
Expected to vest as of March 31, 2023(2) |  |  | 3,050 |  |  | $ | 29.48 |
(1) Includes 520,138 performance-based restricted stock units as of both March 31, 2023 and December 31, 2022, which represents the maximum amount that can vest. (2) Includes 68,300 performance-based restricted stock units.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration